INSTIL BIO INC (TIL) Stock Earnings & Estimates
NASDAQ:TIL - US45783C2008 - Common Stock
28.41 USD
+2.7 (+10.5%)
28.41 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 140K | 34.845K -100.00% | 336.663K | 54.338M | 156.85M 188.66% | 280.28M 78.69% | 410.77M 46.56% | ||||||||
| EBITDA YoY % growth | -6.57M | -33.38M -408.07% | -126.249M -357.79% | -192.941M -29.11% | -90.691M 58.32% | -64.939M 35.08% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.59M | -33.64M -410.47% | -146.713M -362.43% | -218.288M -30.68% | -166.144M 57.20% | -84.607M 34.48% | -84.139M -47.61% | -111.749M -32.81% | -109.686M 1.85% | -99.485M 9.30% | -78.881M 20.71% | 3.636M 104.61% | 102.41M 2,716.56% | 206.65M 101.79% | |
| Operating Margin | N/A | -24,028.57% | -421,044.20% | -64,838.65% | N/A | N/A | N/A | N/A | N/A | N/A | -145.17% | 2.32% | 36.54% | 50.31% | |
| EPS YoY % growth | N/A | N/A | -27.42 | -33.46 -261.54% | -25.10 -292.64% | -12.85 52.52% | -12.34 -8.32% | -10.50 14.87% | -8.06 23.26% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.38 32.81% | -2.55 -40.23% | -2.52 41.62% | -2.72 16.18% | -2.90 -21.94% | -3.38 -32.26% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.038M -68.94% | -20.213M -76.19% | -22.569M -55.86% | -26.405M -46.17% | -30.438M -59.88% | -36.711M -81.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -3.24 -41.48% | -2.53 | -0.71 | -28.19% |
| Q1 2025 Q2Q % growth | -4.32 -15.51% | -2.61 | -1.71 | -65.34% |
| Q4 2024 Q2Q % growth | -1.82 8.54% | -3.25 | 1.43 | 44.04% |
| Q3 2024 Q2Q % growth | -3.54 65.96% | -2.13 | -1.41 | -66.31% |
| Q2 2024 Q2Q % growth | -2.29 18.21% | -3.01 | 0.72 | 23.92% |
| Q1 2024 Q2Q % growth | -3.74 57.50% | -2.25 | -1.49 | -66.05% |
| Q4 2023 Q2Q % growth | -1.99 58.54% | -2.87 | 0.88 | 30.75% |
| Q3 2023 Q2Q % growth | -10.40 -2,318.60% | -2.02 | -8.38 | -414.85% |
| Q2 2023 Q2Q % growth | -2.80 -508.70% | -3.30 | 0.50 | 15.13% |
| Q1 2023 Q2Q % growth | -8.80 -1,995.24% | -3.13 | -5.67 | -181.06% |
| Q4 2022 Q2Q % growth | -4.80 -1,016.28% | -8.35 | 3.55 | 42.51% |
| Q3 2022 Q2Q % growth | -0.43 -30.30% | -0.44 | 0.01 | 2.35% |
| Q2 2022 Q2Q % growth | -0.46 -70.37% | -0.42 | -0.04 | -10.55% |
| Q1 2022 Q2Q % growth | -0.42 36.36% | -0.39 | -0.03 | -8.48% |
| Q4 2021 Q2Q % growth | -0.43 | -0.37 | -0.06 | -17.45% |
| Q3 2021 Q2Q % growth | -0.33 | -0.33 | 0.00 | -0.84% |
| Q2 2021 Q2Q % growth | -0.27 | -0.21 | -0.06 | -30.40% |
| Q1 2021 Q2Q % growth | -0.66 | -0.52 | -0.14 | -26.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 959.5K | -959.5K | -100.00% | |
| Q4 2022 Q2Q % growth | 505K | -505K | -100.00% | |
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.05% | 8.19% | -13.09% | -8.81% |
| Revenue | N/A | N/A | N/A | N/A |